Kapardi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 33.99%
- Ebitda 76.47%
- Net Worth -15.12%
- Total Assets -10.72%
About Kapardi Pharma
Kapardi Pharma Private Limited (KPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 November 2018 (Six years and three months 12 days old ). Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Devender Bakshi, Anupama Bakshi, and Shubham Bakshi serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100HR2018PTC076883
- Company No.
076883
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Kapardi Pharma Private Limited offer?
Kapardi Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Nutritional Supplements.
Who are the key members and board of directors at Kapardi Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devender Bakshi  | Director | 13-Nov-2018 | Current |
| Anupama Bakshi | Director | 13-Nov-2018 | Current |
| Shubham Bakshi | Director | 13-Nov-2018 | Current |
Financial Performance of Kapardi Pharma.
Kapardi Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 33.99% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kapardi Pharma?
Unlock access to Kapardi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kapardi Pharma?
Unlock and access historical data on people associated with Kapardi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kapardi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kapardi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.